[go: up one dir, main page]

LV10912A - 9-(2-Oksietoksi) metilguaninu(acikloviru) vai ta sali vai esteri saturosa farmaceitiska emulsija ellaudeni ar antiviralu aktivitati - Google Patents

9-(2-Oksietoksi) metilguaninu(acikloviru) vai ta sali vai esteri saturosa farmaceitiska emulsija ellaudeni ar antiviralu aktivitati

Info

Publication number
LV10912A
LV10912A LV950090A LV950090A LV10912A LV 10912 A LV10912 A LV 10912A LV 950090 A LV950090 A LV 950090A LV 950090 A LV950090 A LV 950090A LV 10912 A LV10912 A LV 10912A
Authority
LV
Latvia
Prior art keywords
emulsion
acyclovir
polyhydric alcohol
oil
oxetoxy
Prior art date
Application number
LV950090A
Other languages
English (en)
Other versions
LV10912B (en
Inventor
Knud Erik Gebhard-Hansen
Soren Bols Pedersen
Karen Bjornsdottir
Bodil Gyllembourg
Borge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of LV10912A publication Critical patent/LV10912A/lv
Publication of LV10912B publication Critical patent/LV10912B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LVP-95-90A 1992-09-09 1995-04-07 An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof LV10912B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
PCT/DK1993/000288 WO1994005258A1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof

Publications (2)

Publication Number Publication Date
LV10912A true LV10912A (lv) 1995-12-20
LV10912B LV10912B (en) 1996-08-20

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-90A LV10912B (en) 1992-09-09 1995-04-07 An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof

Country Status (27)

Country Link
EP (1) EP0662819B1 (lv)
JP (1) JPH08501089A (lv)
AT (1) ATE137113T1 (lv)
AU (1) AU4945393A (lv)
BG (1) BG62032B1 (lv)
BR (1) BR9307024A (lv)
CA (1) CA2142493A1 (lv)
CZ (1) CZ284007B6 (lv)
DE (1) DE69302396T2 (lv)
DK (1) DK169121B1 (lv)
EE (1) EE03088B1 (lv)
ES (1) ES2086235T3 (lv)
FI (1) FI112777B (lv)
GR (1) GR3019984T3 (lv)
HR (1) HRP931160B1 (lv)
HU (1) HUT72606A (lv)
LT (1) LT3056B (lv)
LV (1) LV10912B (lv)
NO (1) NO308234B1 (lv)
PL (1) PL172663B1 (lv)
RO (1) RO113306B1 (lv)
RU (1) RU2128503C1 (lv)
SI (1) SI9300469A (lv)
SK (1) SK280119B6 (lv)
UA (1) UA41897C2 (lv)
WO (1) WO1994005258A1 (lv)
ZA (1) ZA936661B (lv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
FR2753626B1 (fr) * 1996-09-20 1998-11-06 Centre International De Rech Dermatologiques Galderma Cird Galderma Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
JP2007532697A (ja) * 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
WO2007121318A2 (en) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2008006085A2 (en) * 2006-07-07 2008-01-10 University Of Washington Compositions and methods for predicting inhibitors of protein targets
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US8604081B2 (en) 2009-06-24 2013-12-10 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN114668851B (zh) 2010-12-29 2024-11-01 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
FI951086A0 (fi) 1995-03-08
SI9300469A (en) 1994-03-31
SK280119B6 (sk) 1999-08-06
LTIP959A (en) 1994-05-15
HRP931160B1 (en) 1999-04-30
RU95110930A (ru) 1997-03-27
JPH08501089A (ja) 1996-02-06
EP0662819B1 (en) 1996-04-24
EE03088B1 (et) 1998-06-15
RO113306B1 (ro) 1998-06-30
WO1994005258A1 (en) 1994-03-17
HUT72606A (en) 1996-05-28
UA41897C2 (uk) 2001-10-15
DK111392D0 (da) 1992-09-09
PL172663B1 (pl) 1997-10-31
GR3019984T3 (en) 1996-08-31
BG62032B1 (bg) 1999-01-29
DK111392A (da) 1994-03-10
BR9307024A (pt) 1999-06-29
NO308234B1 (no) 2000-08-21
AU4945393A (en) 1994-03-29
FI951086A7 (fi) 1995-03-08
HU9500702D0 (en) 1995-04-28
HRP931160A2 (en) 1995-12-31
DK169121B1 (da) 1994-08-22
FI112777B (fi) 2004-01-15
EP0662819A1 (en) 1995-07-19
CZ59995A3 (en) 1995-09-13
CA2142493A1 (en) 1994-03-17
LT3056B (en) 1994-10-25
SK29195A3 (en) 1997-01-08
ES2086235T3 (es) 1996-06-16
DE69302396T2 (de) 1996-08-14
RU2128503C1 (ru) 1999-04-10
NO950895L (no) 1995-03-08
NO950895D0 (no) 1995-03-08
BG99484A (bg) 1995-12-29
LV10912B (en) 1996-08-20
DE69302396D1 (de) 1996-05-30
PL307860A1 (en) 1995-06-26
ATE137113T1 (de) 1996-05-15
ZA936661B (en) 1994-05-20
CZ284007B6 (cs) 1998-07-15

Similar Documents

Publication Publication Date Title
LV10912A (lv) 9-(2-Oksietoksi) metilguaninu(acikloviru) vai ta sali vai esteri saturosa farmaceitiska emulsija ellaudeni ar antiviralu aktivitati
US4963555A (en) Formulations of heterocyclic compounds
IE811617L (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
AU643975B2 (en) Pharmaceutical formulation
EP0593562B1 (en) Topical composition containing penciclovir
CA2022632A1 (en) Pharmaceutical formulation
US6469015B1 (en) Pharmaceutical formulation
HK1012242B (en) Topical composition containing penciclovir
WO2005067941A1 (es) Formulacion topica de aciclovir